Register for free
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Amgen (NQ:AMGN)

282.20 +8.23 (+3.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,508,735
Open 274.14
Bid (Size) 280.60 (1)
Ask (Size) 282.20 (1)
Prev. Close 273.97
Today's Range 274.02 - 284.81
52wk Range 253.30 - 335.88
Shares Outstanding 537,700,000
Dividend Yield 3.37%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Healthcare Staffing Giant AMN Healthcare Soars Amidst Landmark Drug-Pricing Agreement
New York, NY – September 30, 2025 – AMN Healthcare Services (NYSE: AMN), a leading provider of healthcare staffing solutions, witnessed a significant upward movement in its stock today, reflecting a... 
Via MarketMinute
Topics Government
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Washington D.C. – September 30, 2025 – The pharmaceutical sector experienced a significant upward surge today, notably led by AbbVie (NYSE: ABBV), following reports of a groundbreaking drug-pricing... 
Via MarketMinute
Topics Economy Government World Trade

Performance

YTD
+8.8%
+8.8%
1 Month
-1.6%
-1.6%
3 Month
-2.9%
-2.9%
6 Month
-8.1%
-8.1%
1 Year
-12.4%
-12.4%

More News

Read More
Amgen Announces $650M Expansion Of US Manufacturing Network After Trump’s Pharma Tariff Announcement
Via Stocktwits
Topics Government
Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know
Via StockStory
Topics Government
Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks
Via Benzinga
Topics ETFs
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever
Via The Motley Fool
Topics ETFs Stocks
Pharma Lobby Announces New Website To Connect Patients With Manufacturer-Direct Purchase Program
Via Stocktwits
Topics Government
Why the Schwab U.S. Dividend Equity ETF Could Be a Top Choice for Dividend Investors in 2025
Via The Motley Fool
Topics ETFs Stocks
Amgen Expands US Manufacturing Network Amid New Tariff Policy
Via Benzinga
Topics Government World Trade
Pharma Tariffs Back In Spotlight On New Trump Threat
Via Investor's Business Daily
Topics ETFs Government World Trade
Global Markets Brace for Impact as New U.S. Tariffs Escalate Trade Tensions Amidst Geopolitical Volatility
Via MarketMinute
Topics Artificial Intelligence Economy Emissions
The Analyst Verdict: Amgen In The Eyes Of 8 Experts
Via Benzinga
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinet
Via Benzinga
Topics Government World Trade
European Advisory Panel Recommends Two AstraZeneca Drugs For Approval
Via Benzinga
Big Pharma's Epicenter Shift: Eli Lilly and the Reshaping of the Weight-Loss Drug Market
Via MarketMinute
Topics Economy Intellectual Property
Johnson & Johnson's Uninterrupted Dividend Growth: Innovation in Medicine and MedTech Drives Strong Q2 2025 Performance
Via MarketMinute
Topics Artificial Intelligence Intellectual Property
Eli Lilly's Ascent: A New Era in Obesity Treatment Driven by Zepbound and Orforglipron
Via MarketMinute
Topics Economy
The Pharmaceutical Revolution: AI, Gene Therapies, and Obesity Drugs Reshape a Trillion-Dollar Market
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
Why Amgen (AMGN) Stock Is Trading Up Today
Via StockStory
Topics Artificial Intelligence
Friday's session: top gainers and losers in the S&P500 index
Via Chartmill
Eli Lilly Poised for Blockbuster Q3 2025 with Skyrocketing EPS and Revenue Projections
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
GLP-1 Titans Clash: Eli Lilly Challenges Novo Nordisk's Dominance in a Spiraling Market Battle
Via MarketMinute
Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes
Via MarketMinute
EMA Backs Amgen Drug For Rare Autoimmune Disorder
Via Benzinga
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session.
Via Chartmill

Frequently Asked Questions

Is Amgen publicly traded?
Yes, Amgen is publicly traded.
What exchange does Amgen trade on?
Amgen trades on the Nasdaq Stock Market
What is the ticker symbol for Amgen?
The ticker symbol for Amgen is AMGN on the Nasdaq Stock Market
What is the current price of Amgen?
The current price of Amgen is 282.20
When was Amgen last traded?
The last trade of Amgen was at 09/30/25 04:00 PM ET
What is the market capitalization of Amgen?
The market capitalization of Amgen is 151.74B
How many shares of Amgen are outstanding?
Amgen has 152B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS